David J. Wustrow

2.8k total citations
54 papers, 1.7k citations indexed

About

David J. Wustrow is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, David J. Wustrow has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Organic Chemistry and 19 papers in Cellular and Molecular Neuroscience. Recurrent topics in David J. Wustrow's work include Receptor Mechanisms and Signaling (15 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Neuropeptides and Animal Physiology (8 papers). David J. Wustrow is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Pharmacological Receptor Mechanisms and Effects (9 papers) and Neuropeptides and Animal Physiology (8 papers). David J. Wustrow collaborates with scholars based in United States, United Kingdom and Netherlands. David J. Wustrow's co-authors include Justin S. Bryans, Lawrence D. Wise, Thomas G. Heffner, M. Duff Davis, Thomas A. Pugsley, Thomas R. Belliotti, Kim Zoski, Hyacinth C. Akunne, Steven Z. Whetzel and Ann E. Corbin and has published in prestigious journals such as Blood, Neurology and Cancer Research.

In The Last Decade

David J. Wustrow

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Wustrow United States 20 746 611 491 207 194 54 1.7k
Celia Dominguez United States 27 1.1k 1.5× 697 1.1× 412 0.8× 233 1.1× 142 0.7× 79 2.2k
Timothy Harrison United Kingdom 25 1.1k 1.4× 406 0.7× 611 1.2× 217 1.0× 199 1.0× 52 1.7k
J. Jeffry Howbert United States 20 804 1.1× 352 0.6× 532 1.1× 125 0.6× 253 1.3× 38 1.5k
Stephen R. Fletcher United States 20 941 1.3× 640 1.0× 323 0.7× 182 0.9× 97 0.5× 38 1.8k
Edward Leung Italy 24 1.0k 1.4× 364 0.6× 379 0.8× 182 0.9× 156 0.8× 52 2.2k
Wha Bin Im United States 28 1.4k 1.9× 435 0.7× 771 1.6× 165 0.8× 177 0.9× 85 2.3k
Mohammed A. Kashem United States 25 858 1.2× 301 0.5× 456 0.9× 157 0.8× 170 0.9× 58 1.8k
Margot W. Beukers Netherlands 27 1.0k 1.4× 410 0.7× 418 0.9× 114 0.6× 103 0.5× 42 1.9k
Grazia Lombardi Italy 29 1.1k 1.5× 212 0.3× 792 1.6× 113 0.5× 216 1.1× 66 2.3k
Gina H. Lu United States 21 1.1k 1.5× 460 0.8× 388 0.8× 132 0.6× 180 0.9× 32 2.0k

Countries citing papers authored by David J. Wustrow

Since Specialization
Citations

This map shows the geographic impact of David J. Wustrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Wustrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Wustrow more than expected).

Fields of papers citing papers by David J. Wustrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Wustrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Wustrow. The network helps show where David J. Wustrow may publish in the future.

Co-authorship network of co-authors of David J. Wustrow

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Wustrow. A scholar is included among the top collaborators of David J. Wustrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Wustrow. David J. Wustrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bissonnette, Robert, Janet DuBois, Paola Facheris, et al.. (2023). Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study. Allergy. 79(4). 924–936. 17 indexed citations
2.
Jorapur, Aparna, Lisa A. Marshall, Mengshu Xu, et al.. (2022). EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22. PLoS Pathogens. 18(1). e1010200–e1010200. 19 indexed citations
3.
Guttman‐Yassky, Emma, Ana B. Pavel, Paola Facheris, et al.. (2022). 822 RPT193, a CCR4 inhibitor, improves the inflammatory skin transcriptomic profile in patients with atopic dermatitis. Journal of Investigative Dermatology. 142(8). S143–S143. 1 indexed citations
4.
Jorapur, Aparna, Oezcan Talay, David J. Wustrow, et al.. (2020). 561 Development and first-in-human characterization of a potent oral CCR4 antagonist for the treatment of atopic dermatitis. Journal of Investigative Dermatology. 140(7). S77–S77. 1 indexed citations
5.
Wustrow, David J., et al.. (2013). Comparative Gastric Irritation of the Fumaric Acid Esters Dimethyl Fumarate (DMF) and XP23829 in Rat and Monkey (P01.159). Neurology. 80(7_supplement). 4 indexed citations
6.
Xu, Feng, Jian Lu Chen, Tania Chernov-Rogan, et al.. (2011). Discovery of a novel potent GABAB receptor agonist. Bioorganic & Medicinal Chemistry Letters. 21(21). 6582–6585. 18 indexed citations
7.
Wustrow, David J., George D. Maynard, Jun Yuan, et al.. (2008). Aminopyrazine CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 18(11). 3376–3381. 7 indexed citations
8.
Broom, Daniel C., David J. Matson, Elizabeth M. Bradshaw, et al.. (2008). Characterization of N-(Adamantan-1-ylmethyl)-5-[(3 R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation. Journal of Pharmacology and Experimental Therapeutics. 327(3). 620–633. 67 indexed citations
9.
Chandrasekhar, Jayaraman, David C. Ihle, David J. Wustrow, et al.. (2008). 1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 5027–5031. 9 indexed citations
10.
Wustrow, David J., Thomas R. Belliotti, Thomas Capiris, et al.. (2008). Oxadiazolone bioisosteres of pregabalin and gabapentin. Bioorganic & Medicinal Chemistry Letters. 19(1). 247–250. 11 indexed citations
11.
Belliotti, Thomas R., Thomas Capiris, Jack J. Kinsora, et al.. (2005). Structure−Activity Relationships of Pregabalin and Analogues That Target the α2-δ Protein. Journal of Medicinal Chemistry. 48(7). 2294–2307. 173 indexed citations
12.
Yuen, Po‐wai, et al.. (2005). Heteroaromatic side-chain analogs of pregabalin. Bioorganic & Medicinal Chemistry Letters. 16(9). 2329–2332. 14 indexed citations
13.
Akunne, Hyacinth C., Kim Zoski, M. Duff Davis, et al.. (2000). PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects. Neuropharmacology. 39(7). 1197–1210. 5 indexed citations
14.
Feifel, David, Tammi L. Reza, David J. Wustrow, & M. Duff Davis. (1999). Novel Antipsychotic-Like Effects on Prepulse Inhibition of Startle Produced by a Neurotensin Agonist. Journal of Pharmacology and Experimental Therapeutics. 288(2). 710–713. 73 indexed citations
15.
Bryans, Justin S. & David J. Wustrow. (1999). 3-Substituted GABA analogs with central nervous system activity: A review. Medicinal Research Reviews. 19(2). 149–177. 254 indexed citations
16.
Wustrow, David J., Thomas Capiris, Hyacinth C. Akunne, et al.. (1998). Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(16). 2067–2070. 111 indexed citations
17.
Wustrow, David J., Hyacinth C. Akunne, Thomas R. Belliotti, et al.. (1996). An aminopyrimidine with potent affinity for both dopamine and serotonin reoeptors. European Neuropsychopharmacology. 6. S4–107. 6 indexed citations
18.
Pugsley, Thomas A., Hyacinth C. Akunne, Steven Z. Whetzel, et al.. (1995). Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists. Peptides. 16(1). 37–44. 30 indexed citations
19.
Banks, William A., David J. Wustrow, Wayne L. Cody, M. Duff Davis, & Abba J. Kastin. (1995). Permeability of the blood-brain barrier to the neurotensin8–13 analog NT1. Brain Research. 695(1). 59–63. 27 indexed citations
20.
Mulcahy, Ríona, David J. Wustrow, Richard R. Hark, & Andrew S. Kende. (1987). Enhancement of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) toxicity by acetohydroxamic acid analogues of 3-nitropyrazole in vitro. Investigational New Drugs. 5(3). 281–287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celia Dominguez Breakdown of academic impact, for papers by Timothy Harrison Breakdown of academic impact, for papers by J. Jeffry Howbert Breakdown of academic impact, for papers by Stephen R. Fletcher Breakdown of academic impact, for papers by Edward Leung Breakdown of academic impact, for papers by Wha Bin Im Breakdown of academic impact, for papers by Mohammed A. Kashem Breakdown of academic impact, for papers by Margot W. Beukers Breakdown of academic impact, for papers by Grazia Lombardi Breakdown of academic impact, for papers by Gina H. Lu
Rankless by CCL
2026